Phase II/III Study of AZD2816, for the Prevention of COVID-19 in Adults
Clinical trial NCT04973449 · COMPLETED
Trial details
- NCT number
- NCT04973449
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-27
- Primary completion
- 2022-02-04
- Enrollment
- 2843
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.